REPLIMUNE GROUP INC (REPL)

US76029N1063 - Common Stock

10.9  -0.16 (-1.45%)

Fundamental Rating

2

Taking everything into account, REPL scores 2 out of 10 in our fundamental rating. REPL was compared to 574 industry peers in the Biotechnology industry. REPL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. REPL is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year REPL has reported negative net income.
In the past year REPL has reported a negative cash flow from operations.
In the past 5 years REPL always reported negative net income.
REPL had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -44.25%, REPL is in line with its industry, outperforming 53.77% of the companies in the same industry.
The Return On Equity of REPL (-57.62%) is better than 60.60% of its industry peers.
Industry RankSector Rank
ROA -44.25%
ROE -57.62%
ROIC N/A
ROA(3y)-32.26%
ROA(5y)-26.83%
ROE(3y)-39.24%
ROE(5y)-32.52%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for REPL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

The number of shares outstanding for REPL has been increased compared to 1 year ago.
Compared to 5 years ago, REPL has more shares outstanding
Compared to 1 year ago, REPL has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.30, we must say that REPL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.30, REPL is in the better half of the industry, outperforming 64.10% of the companies in the same industry.
A Debt/Equity ratio of 0.18 indicates that REPL is not too dependend on debt financing.
The Debt to Equity ratio of REPL (0.18) is worse than 67.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 1.3
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 10.72 indicates that REPL has no problem at all paying its short term obligations.
REPL has a Current ratio of 10.72. This is in the better half of the industry: REPL outperforms 78.46% of its industry peers.
REPL has a Quick Ratio of 10.72. This indicates that REPL is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 10.72, REPL is doing good in the industry, outperforming 78.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.72
Quick Ratio 10.72

1

3. Growth

3.1 Past

REPL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.00%.
EPS 1Y (TTM)-8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10.81%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, REPL will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.58% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.59%
EPS Next 2Y6.86%
EPS Next 3Y13.95%
EPS Next 5Y14.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

REPL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for REPL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as REPL's earnings are expected to grow with 13.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.86%
EPS Next 3Y13.95%

0

5. Dividend

5.1 Amount

REPL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REPLIMUNE GROUP INC

NASDAQ:REPL (7/17/2024, 8:47:02 AM)

10.9

-0.16 (-1.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap731.17M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.25%
ROE -57.62%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 10.72
Quick Ratio 10.72
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-8%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-4.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y